CHEMOTHERAPY IN WOMEN WITH TROPHOBLASTIC DISEASE: CHORIOCARCINOMA, CHORIOADENOMA DESTRUENS, AND COMPLICATED HYDATIDIFORM MOLE.
D000970:Antineoplastic Agents; D002822:Choriocarcinoma; D003520:Cyclophosphamide; D003609:Dactinomycin; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole; D002820:Hydatidiform Mole, Invasive; D008466:Mechlorethamine; D015122:Mercaptopurine; D008727:Methotrexate; D011247:Pregnancy; D014594:Uterine Neoplasms; D014747:Vinblastine
D000970:Antineoplastic Agents; D003609:Dactinomycin; D008466:Mechlorethamine; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate
ACTINOMYCIN; ANTINEOPLASTIC AGENTS; CHORIOADENOMA; CHORIOCARCINOMA; CYCLOPHOSPHAMIDE; HYDATIDIFORM MOLE; MECHLORETHAMINE; MERCAPTOPURINE; METHOTREXATE; VINBLASTINE